Loading…
Securing America’s Medicine Cabinet Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Securing America's Medicine Cabinet Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2023 · fourth_quarter · Labor Issues/Antitrust/Workplace
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Rights and responsibilities of domestic workers and domestic worker employers. Revisions to Domestic Workers Bill of Rights Act, which will be similar to HR 4826, S.2589 (117th Congress 2021-2022). Labor rights topics covered include written agreements, safety and health, overtime coverage for live-in domestic workers, sick pay, anti-discrimination and anti-harassment coverage for domestic workers, with a focus this quarter on occupational safety and health.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Labor Issues/Antitrust/Workplace
Rights and responsibilities of domestic workers and domestic worker employers. Revisions to Domestic Workers Bill of Rights Act, which will be similar to HR 4826, S.2589 (117th Congress 2021-2022). Labor rights topics covered include written agreements, safety and health, overtime coverage for live-in domestic workers, sick pay, anti-discrimination and anti-harassment coverage for domestic workers. Develop information to be provided to Office of Science and Technology Policy for its Worker Surveillance and Automated Management Request for Information about examples of surveillance and automated management of domestic workers, including house cleaners, nannies, and home care workers.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
2023 · second_quarter · Labor Issues/Antitrust/Workplace
Rights and responsibilities of domestic workers and domestic worker employers. Revisions to Domestic Workers Bill of Rights Act, which will be similar to HR 4826, S.2589 (117th Congress 2021-2022). Labor rights topics covered include written agreements, safety and health, overtime coverage for live-in domestic workers, sick pay, anti-discrimination and anti-harassment coverage for domestic workers. Develop information to be provided to Office of Science and Technology Policy for its Worker Surveillance and Automated Management Request for Information about examples of surveillance and automated management of domestic workers, including house cleaners, nannies, and home care workers.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
2023 · second_quarter · Labor Issues/Antitrust/Workplace
Rights and responsibilities of domestic workers and domestic worker employers. Revisions to Domestic Workers Bill of Rights Act, which will be similar to HR 4826, S.2589 (117th Congress 2021-2022). Labor rights topics covered include written agreements, safety and health, overtime coverage for live-in domestic workers, sick pay, anti-discrimination and anti-harassment coverage for domestic workers. Develop information to be provided to Office of Science and Technology Policy for its Worker Surveillance and Automated Management Request for Information about examples of surveillance and automated management of domestic workers, including house cleaners, nannies, and home care workers.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
2023 · first_quarter · Labor Issues/Antitrust/Workplace
Rights and responsibilities of domestic workers and domestic worker employers. Revisions to Domestic Workers Bill of Rights Act, which will be similar to HR 4826, S.2589 (117th Congress 2021-2022). Labor rights topics covered include written agreements, safety and health, overtime coverage for live-in domestic workers, sick pay, anti-discrimination and anti-harassment coverage for domestic workers.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Civil Rights/Civil Liberties
Rights and responsibilities of domestic workers and domestic worker employers. Revisions to Domestic Workers Bill of Rights Act, which will be similar to HR 4826, S.2589 (117th Congress 2021-2022). Labor rights topics covered include written agreements, safety and health, overtime coverage for live-in domestic workers, sick pay, anti-discrimination and anti-harassment coverage for domestic workers.
Client expense: Not reported · Firm income: Not reported
2023 · first_quarter · Labor Issues/Antitrust/Workplace
Rights and responsibilities of domestic workers and domestic worker employers. Revisions to Domestic Workers Bill of Rights Act, which will be similar to HR 4826, S.2589 (117th Congress 2021-2022). Labor rights topics covered include written agreements, safety and health, overtime coverage for live-in domestic workers, sick pay, anti-discrimination and anti-harassment coverage for domestic workers.
Client expense: Not reported · Firm income: Not reported
2022 · fourth_quarter · Manufacturing
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act (H.R.4369) Securing Americas Medicine Cabinet Act of 2021 (S. 2589)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Science/Technology
H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics (provisions relating to the creation of the Advanced Research Projects Agency-Health, university centers of excellence in advanced and continuous pharmaceutical manufacturing, pandemic preparedness university centers of excellence, and research at regional biocontainment labs). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5388 and S. 2740: Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production (ALL). H.R. 2617: Consolidated Appropriations Act, 2023 Making consolidated appropriations for the fiscal year ending September 30, 2023, and for providing emergency assistance for the situation in Ukraine, and for other purposes (provisions relating to university centers of excellence in advanced and continuous pharmaceutical manufacturing and the authorization of the Advanced Research Projects Agency-Health). Federal policy changes regarding fetal tissue research, biomedical research involving animals, research security, and facilities and administrative costs associated with research grants. White House and Executive Branch implementation of the CHIPS and Science Act.
2022 · third_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Science/Technology
H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 1260: United States Innovation and Competition Act of 2021 A bill to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). H.R. 4521: America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (COMPETES) Act of 2022 Vehicle for the Houses comprehensive innovation and competitiveness legislation (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education; immigration provisions relating to advanced degree holders from U.S. institutions of higher education; and provision relating to university centers of excellence in advanced and continuous pharmaceutical manufacturing). H.R. 4346: CHIPS and Science Act Vehicle for bipartisan legislation to support domestic semiconductor research and development and reauthorize major science agencies (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics (provisions relating to the creation of the Advanced Research Projects Agency-Health, university centers of excellence in advanced and continuous pharmaceutical manufacturing, pandemic preparedness university centers of excellence, and research at regional biocontainment labs). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). H.R. 2225: National Science Foundation for the Future Act To authorize appropriations for fiscal years 2022, 2023, 2024, 2025, and 2026 for the National Science Foundation, and for other purposes (ALL). H.R. 3593: Department of Energy Science for the Future Act To provide guidance for and investment in the research and development activities of the Department of Energy Office of Science, and for other purposes (ALL). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5388 and S. 2740: Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production (ALL). S. 4900 SBIR and STTR Extension Act of 2022 A bill to reauthorize the SBIR and STTR programs and pilot programs, and for other purposes (ALL). Federal policy changes regarding fetal tissue research, biomedical research involving animals, research security, and facilities and administrative costs associated with research grants. Pending federal legislation to enhance university climate research, service, and resiliency.
2022 · third_quarter · Manufacturing
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act (H.R.4369) Securing Americas Medicine Cabinet Act of 2021 (S. 2589)
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Science/Technology
H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 1260: United States Innovation and Competition Act of 2021 A bill to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). H.R. 4521: America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (COMPETES) Act of 2022 Vehicle for the Houses comprehensive innovation and competitiveness legislation (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education; immigration provisions relating to advanced degree holders from U.S. institutions of higher education; and provision relating to university centers of excellence in advanced and continuous pharmaceutical manufacturing). S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics (provisions relating to the creation of the Advanced Research Projects Agency-Health, university centers of excellence in advanced and continuous pharmaceutical manufacturing, pandemic preparedness university centers of excellence, and research at regional biocontainment labs). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). H.R. 2225: National Science Foundation for the Future Act To authorize appropriations for fiscal years 2022, 2023, 2024, 2025, and 2026 for the National Science Foundation, and for other purposes (ALL). H.R. 3593: Department of Energy Science for the Future Act To provide guidance for and investment in the research and development activities of the Department of Energy Office of Science, and for other purposes (ALL). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5388 and S. 2740: Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production (ALL). Federal policy changes regarding fetal tissue research, biomedical research involving animals, research security, and facilities and administrative costs associated with research grants. Pending federal legislation to enhance university climate research, service, and resiliency.
2022 · second_quarter · Manufacturing
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act (H.R.4369) Securing Americas Medicine Cabinet Act of 2021 (S. 2589)
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2022 and FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2022 and FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Science/Technology
H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 1260 and H.R. 2731: United States Innovation and Competition Act of 2021 A bill to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). H.R. 4521: America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (COMPETES) Act of 2022 Vehicle for the Houses comprehensive innovation and competitiveness legislation (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education; immigration provisions relating to advanced degree holders from U.S. institutions of higher education; and provision relating to advanced and continuous pharmaceutical manufacturing university centers of excellence). S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics (provisions relating to the creation of the Advanced Research Projects Agency-Health, advanced and continuous pharmaceutical manufacturing university centers of excellence, pandemic preparedness university centers of excellence, and research at regional biocontainment labs). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). H.R. 2225: National Science Foundation for the Future Act To authorize appropriations for fiscal years 2022, 2023, 2024, 2025, and 2026 for the National Science Foundation, and for other purposes (ALL). H.R. 3593: Department of Energy Science for the Future Act To provide guidance for and investment in the research and development activities of the Department of Energy Office of Science, and for other purposes (ALL). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5388 and S. 2740: Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production (ALL). Federal policy changes regarding fetal tissue research and research security.
2022 · first_quarter · Manufacturing
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act (H.R.4369) Securing Americas Medicine Cabinet Act of 2021 (S. 2589) Digital Enterprise and Manufacturing Technologies Consortium Advanced Manufacturing, Materials, and Processes (AMMP) Consortium
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2022 and FY2023 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2022 and FY2023, ARS Extramural Research, ARS Buildings and Facilities FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Science/Technology
H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 1260 and H.R. 2731: United States Innovation and Competition Act of 2021 A bill to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). H.R. 2225: National Science Foundation for the Future Act To authorize appropriations for fiscal years 2022, 2023, 2024, 2025, and 2026 for the National Science Foundation, and for other purposes (ALL). H.R. 3593: Department of Energy Science for the Future Act To provide guidance for and investment in the research and development activities of the Department of Energy Office of Science, and for other purposes (ALL). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). Federal policy changes regarding fetal tissue research and research security.
2021 · fourth_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2021 and FY2022, ARS Extramural Research FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2021 and FY2022 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2021 and FY2022 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2021 and FY2022, ARS Extramural Research FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Manufacturing
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act (H.R.4639) Advanced Manufacturing/Battery Production Legislation (Senate Discussion Draft) Securing Americas Medicine Cabinet Act of 2021 (S. 2589)
Client expense: $80,000 · Firm income: Not reported
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2021 · third_quarter · Science/Technology
H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 1260 and H.R. 2731: United States Innovation and Competition Act of 2021 A bill to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). H.R. 2225: National Science Foundation for the Future Act To authorize appropriations for fiscal years 2022, 2023, 2024, 2025, and 2026 for the National Science Foundation, and for other purposes (ALL). H.R. 3593: Department of Energy Science for the Future Act To provide guidance for and investment in the research and development activities of the Department of Energy Office of Science, and for other purposes (ALL). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). Federal policy changes regarding fetal tissue research. Pending legislation to expand upon the 21st Century Cures Act of 2015 and authorize the creation of an Advanced Projects Research Agency for Health (ARPA-H).
2021 · third_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2021 and FY2022 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2021 and FY2022, ARS Extramural Research FDA Nutrition Labeling Regulatory Issues H.R. 4369 - Continuous Pharmaceutical Manufacturing Act S.2589 - Securing Americas Medicine Cabinet Act of 2021
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Manufacturing
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2020 (H.R.4866) Advanced Manufacturing/Battery Production Legislation (Senate Discussion Draft) Securing Americas Medicine Cabinet Act of 2021 (S. 2589)
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2021 · third_quarter · Health Issues
Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, FY2021 and FY2022 NIH Extramural Research Programs and Funding; Reimbursement Issues, Comparative Effectiveness Related Issues and Initiatives; and Minority Health Issues; HRSA Nursing Programs and Workforce Training; Regenerative Engineering; Indirect Cost Reimbursement Issues; Medicare Accelerated and Advance Payment Programs H.R. 4369- Continuous Pharmaceutical Manufacturing Act S. 2589- Securing America's Medicine Cabinet Act of 2021
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Agriculture
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2021 and FY2022, ARS Extramural Research FDA Nutrition Labeling Regulatory Issues H.R. 4369- Continuous Pharmaceutical Manufacturing Act S. 2589- Securing America's Medicine Cabinet Act of 2021
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Taxation/Internal Revenue Code
General tax legislative and regulatory issues; H.R. 4509 (2019); and S. 2589 (2019).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE